Clinical trial · Observational
Local Control After Robot-assisted Supraglottic Laryngectomy
Evaluation of Local Control 2 Years After Robot-assisted Supraglottic Laryngectomy: a Multicenter Retrospective Study
NCT03357107CI-TRIAL-00030607completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Transoral robotic surgery is an option to treat supraglottic squamous cell carcinomas. Oncological outcomes 2 years after transoral robotic surgery for supraglottic laryngectomy were studied.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Supraglottic Squamous Cell Carcinoma | Supraglottic Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Transoral robotic surgery (TORS) | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Local control
- timeFrame
- 2 years after surgery
- description
- Proportion of patients without cancer recurrence 2 years after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Men or women over 18 years of age * Patients with supra-glottic squamous cell carcinoma from T1 to T3, all stages N * Patients with a robot assisted supra-glottic laryngectomy with at least 2 years follow-up Exclusion Criteria: * Patients for whom follow-up of at least 2 years has not been achieved; * Major patients protected by the law (under guardianship or guardianship); * Patients who expressed opposition to their participation in the study.
References
Publications (0)
Data not yet available
No reference posted for this study.